{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:44:16Z","timestamp":1772012656015,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.thorsurg.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T19:16:44Z","timestamp":1601579804000},"page":"481-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Taken Together"],"prefix":"10.1016","volume":"30","author":[{"given":"Kimberly J.","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja M.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea S.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/ers.10.35","article-title":"Surgery for malignant pleural mesothelioma","volume":"4","author":"Sugarbaker","year":"2010","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population","volume":"5","author":"Flores","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"282145","DOI":"10.1155\/2015\/282145","article-title":"Frequency of surgery in black patients with malignant pleural mesothelioma","volume":"2015","author":"Taioli","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.semtcvs.2009.06.008","article-title":"Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy\/decortication","volume":"21","author":"Flores","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semtcvs.2009.07.007","article-title":"Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy\/decortication","volume":"21","author":"Wolf","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","article-title":"Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients","volume":"31","author":"Butchart","year":"1976","journal-title":"Thorax"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1186\/s12885-018-5064-4","article-title":"Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"18","author":"Schwartz","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1010-7940(01)00995-2","article-title":"Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control","volume":"20","author":"Martin-Ucar","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib14","first-page":"2569","article-title":"Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma","volume":"25","author":"Tanaka","year":"2017","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.002_bib15","first-page":"4107","article-title":"Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma","volume":"27","author":"Tanaka","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jso.21261","article-title":"Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"100","author":"Ambrogi","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1245\/s10434-011-2171-8","article-title":"Clinical impact of extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"19","author":"Ambrogi","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib18","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00268-017-4264-4","article-title":"Influence of Pleurectomy and Decortication in Health-Related Quality of Life Among Patients with Malignant Pleural Mesothelioma","volume":"42","author":"Vigneswaran","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib19","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jtcvs.2017.11.060","article-title":"Mesothelioma: live to fight another day","volume":"155","author":"Wolf","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib20","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/annonc\/mdm501","article-title":"Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)","volume":"19","author":"Castagneto","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","article-title":"Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaive patients with malignant pleural mesothelioma: results of the International Expanded Access Program","volume":"3","author":"Santoro","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/cncr.11405","article-title":"Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study","volume":"97","author":"Favaretto","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.bjc.6600505","article-title":"A\u00a0multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma","volume":"87","author":"Nowak","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2007.02.004","article-title":"Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results","volume":"57","author":"Rea","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jjco\/hyn145","article-title":"A\u00a0feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma","volume":"39","author":"Yamanaka","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/17476348.2017.1338951","article-title":"Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma","volume":"11","author":"Marulli","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","article-title":"Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection","volume":"145","author":"Sugarbaker","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1245\/s10434-008-9899-9","article-title":"Surgical treatment in the management of malignant pleural mesothelioma: a single institution's experience","volume":"15","author":"van Sandick","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib30","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.21037\/jtd.2019.04.93","article-title":"Pleurectomy\/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma","volume":"11","author":"Klotz","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(13)70381-4","article-title":"Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial","volume":"14","author":"Calabro","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(15)00092-2","article-title":"Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study","volume":"3","author":"Calabro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(17)30446-1","article-title":"Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Maio","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S2213-2600(18)30151-6","article-title":"Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study","volume":"6","author":"Calabro","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1200\/JCO.2016.68.3672","article-title":"Mesothelin immunotherapy for cancer: ready for prime time?","volume":"34","author":"Hassan","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib38","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1158\/1078-0432.CCR-14-0804","article-title":"Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma","volume":"20","author":"Hassan","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0003-4975(96)01228-3","article-title":"Patterns of failure after trimodality therapy for malignant pleural mesothelioma","volume":"63","author":"Baldini","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.21037\/atm.2017.06.25","article-title":"Malignant pleural mesothelioma: adjuvant therapy with radiation therapy","volume":"5","author":"Rosenzweig","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02303746","article-title":"Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib42","doi-asserted-by":"crossref","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a Surveillance, Epidemiology, and End Results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib43","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.ijrobp.2016.06.323","article-title":"Definitive Radiation Therapy Is Associated With Improved Survival in Non-Metastatic Malignant Pleural Mesothelioma","volume":"96","author":"Ohri","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","article-title":"Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"8","author":"Gomez","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijrobp.2014.08.343","article-title":"Hemithoracic intensity modulated radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis","volume":"91","author":"Chance","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib46","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2014.05.032","article-title":"Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma","volume":"90","author":"Rimner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib48","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma","volume":"34","author":"Rimner","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib49","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jtho.2017.02.026","article-title":"Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma","volume":"12","author":"Shaikh","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A\u00a0feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the \"SMART\" approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.002_bib51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:34:36Z","timestamp":1761546876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412720300645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1547412720300645"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.002","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taken Together","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}